454 related articles for article (PubMed ID: 19808300)
1. Detection of endogenous B-type natriuretic peptide at very low concentrations in patients with heart failure.
Niederkofler EE; Kiernan UA; O'Rear J; Menon S; Saghir S; Protter AA; Nelson RW; Schellenberger U
Circ Heart Fail; 2008 Nov; 1(4):258-64. PubMed ID: 19808300
[TBL] [Abstract][Full Text] [Related]
2. Comparison of mass spectrometry and clinical assay measurements of circulating fragments of B-type natriuretic peptide in patients with chronic heart failure.
Miller WL; Phelps MA; Wood CM; Schellenberger U; Van Le A; Perichon R; Jaffe AS
Circ Heart Fail; 2011 May; 4(3):355-60. PubMed ID: 21292992
[TBL] [Abstract][Full Text] [Related]
3. Evidence for functional heterogeneity of circulating B-type natriuretic peptide.
Liang F; O'Rear J; Schellenberger U; Tai L; Lasecki M; Schreiner GF; Apple FS; Maisel AS; Pollitt NS; Protter AA
J Am Coll Cardiol; 2007 Mar; 49(10):1071-8. PubMed ID: 17349887
[TBL] [Abstract][Full Text] [Related]
4. Low prevalence of B-type natriuretic peptide levels < 100 pg/mL in patients with heart failure at hospital discharge.
Hogenhuis J; Voors AA; Jaarsma T; Hillege HL; Hoes AW; van Veldhuisen DJ
Am Heart J; 2006 May; 151(5):1012.e1-5. PubMed ID: 16644323
[TBL] [Abstract][Full Text] [Related]
5. How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure. Results from the Breathing Not Properly Multinational Study.
Daniels LB; Clopton P; Bhalla V; Krishnaswamy P; Nowak RM; McCord J; Hollander JE; Duc P; Omland T; Storrow AB; Abraham WT; Wu AH; Steg PG; Westheim A; Knudsen CW; Perez A; Kazanegra R; Herrmann HC; McCullough PA; Maisel AS
Am Heart J; 2006 May; 151(5):999-1005. PubMed ID: 16644321
[TBL] [Abstract][Full Text] [Related]
6. Relationship between anemia, cardiac troponin I, and B-type natriuretic peptide levels and mortality in patients with advanced heart failure.
Ralli S; Horwich TB; Fonarow GC
Am Heart J; 2005 Dec; 150(6):1220-7. PubMed ID: 16338262
[TBL] [Abstract][Full Text] [Related]
7. Acute phosphodiesterase 5 inhibition mimics hemodynamic effects of B-type natriuretic peptide and potentiates B-type natriuretic peptide effects in failing but not normal canine heart.
Forfia PR; Lee M; Tunin RS; Mahmud M; Champion HC; Kass DA
J Am Coll Cardiol; 2007 Mar; 49(10):1079-88. PubMed ID: 17349888
[TBL] [Abstract][Full Text] [Related]
8. Plasma BNP and NT-proBNP assays by automated immunoanalyzers: analytical and clinical study.
Bionda C; Bergerot C; Ardail D; Rodriguez-Lafrasse C; Rousson R
Ann Clin Lab Sci; 2006; 36(3):299-306. PubMed ID: 16951271
[TBL] [Abstract][Full Text] [Related]
9. BNP in overweight and obese patients with heart failure: an analysis based on the BNP-LV diastolic wall stress relationship.
Iwanaga Y; Kihara Y; Niizuma S; Noguchi T; Nonogi H; Kita T; Goto Y
J Card Fail; 2007 Oct; 13(8):663-7. PubMed ID: 17923359
[TBL] [Abstract][Full Text] [Related]
10. B-type natriuretic Peptide-guided treatment for predicting outcome in patients hospitalized in sub-intensive care unit with acute heart failure.
Valle R; Aspromonte N; Giovinazzo P; Carbonieri E; Chiatto M; di Tano G; Feola M; Milli M; Fontebasso A; Barro S; Bardellotto S; Milani L
J Card Fail; 2008 Apr; 14(3):219-24. PubMed ID: 18381185
[TBL] [Abstract][Full Text] [Related]
11. Comparison of midregional pro-atrial and B-type natriuretic peptides in chronic heart failure: influencing factors, detection of left ventricular systolic dysfunction, and prediction of death.
Moertl D; Berger R; Struck J; Gleiss A; Hammer A; Morgenthaler NG; Bergmann A; Huelsmann M; Pacher R
J Am Coll Cardiol; 2009 May; 53(19):1783-90. PubMed ID: 19422985
[TBL] [Abstract][Full Text] [Related]
12. Does clinician's knowledge of B-type natriuretic peptide levels translate to improvement of quality of life and less hospitalization days in patients with heart failure?
Ancheta IB; Evans M; Miller AB; Chiong JR; Battie C
Prog Cardiovasc Nurs; 2009 Mar; 24(1):12-8. PubMed ID: 19261138
[TBL] [Abstract][Full Text] [Related]
13. Rapid assay brain natriuretic peptide and troponin I in patients hospitalized with decompensated heart failure (from the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness Trial).
Shah MR; Hasselblad V; Tasissa G; Christenson RH; Binanay C; O'Connor CM; Ohman EM; Stevenson LW; Califf RM
Am J Cardiol; 2007 Nov; 100(9):1427-33. PubMed ID: 17950802
[TBL] [Abstract][Full Text] [Related]
14. Urinary B-type natriuretic peptide levels in the diagnosis and prognosis of heart failure.
Cortés R; Rivera M; Salvador A; García de Burgos F; Bertomeu V; Roselló-Lletí E; Martínez-Dolz L; Payá R; Almenar L; Portolés M
J Card Fail; 2007 Sep; 13(7):549-55. PubMed ID: 17826645
[TBL] [Abstract][Full Text] [Related]
15. Brain natriuretic peptide and N-terminal pro-B-type natriuretic peptide show a different profile in response to acute decompensated heart failure treatment.
Di Somma S; Magrini L; Tabacco F; Marino R; Talucci V; Marrocco F; Cardelli P; Ferri E; Pittoni V
Congest Heart Fail; 2008; 14(5):245-50. PubMed ID: 18983287
[TBL] [Abstract][Full Text] [Related]
16. Altered sodium intake affects plasma concentrations of BNP but not proBNP in healthy individuals and patients with compensated heart failure.
Damgaard M; Goetze JP; Norsk P; Gadsbøll N
Eur Heart J; 2007 Nov; 28(22):2726-31. PubMed ID: 17942579
[TBL] [Abstract][Full Text] [Related]
17. Impact of systemic hypertension on the diagnostic performance of B-type natriuretic peptide in patients with acute dyspnea.
Pahle AS; Sørli D; Omland T; Knudsen CW; Westheim A; Wu AH; Steg PG; McCord J; Nowak RM; Hollander JE; Storrow AB; Abraham WT; McCullough PA; Maisel A
Am J Cardiol; 2009 Oct; 104(7):966-71. PubMed ID: 19766765
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the analytical performance characteristics of the Bayer ACS:180 B-type natriuretic peptide (BNP) assay.
Wians FH; Wilson BA; Grant A; Bailey J; Gheorghiu I; Conarpe C; Mindicino H; Thakur K; Belenky A; Despres N; Bluestein B
Clin Chim Acta; 2005 Mar; 353(1-2):147-55. PubMed ID: 15698602
[TBL] [Abstract][Full Text] [Related]
19. B-type natriuretic peptide as a marker of heart failure: new insights from biochemistry and clinical implications.
Vanderheyden M; Vrints C; Verstreken S; Bartunek J; Beunk J; Goethals M
Biomark Med; 2010 Apr; 4(2):315-20. PubMed ID: 20406072
[TBL] [Abstract][Full Text] [Related]
20. Lipolytic effects of B-type natriuretic peptide 1-32 in adipose tissue of heart failure patients compared with healthy controls.
Polak J; Kotrc M; Wedellova Z; Jabor A; Malek I; Kautzner J; Kazdova L; Melenovsky V
J Am Coll Cardiol; 2011 Sep; 58(11):1119-25. PubMed ID: 21884948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
